Published in PLoS One on June 13, 2013
Preparation and therapeutic evaluation of (188)Re-thermogelling emulsion in rat model of hepatocellular carcinoma. Int J Nanomedicine (2014) 0.75
Generating Virtual Patients by Multivariate and Discrete Re-Sampling Techniques. Pharm Res (2015) 0.75
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol (2002) 82.19
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med (2004) 71.08
Sorafenib in advanced hepatocellular carcinoma. N Engl J Med (2008) 54.30
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol (2008) 23.93
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med (2003) 17.23
Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol (2002) 13.81
Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer (1954) 12.77
Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology (2004) 6.98
Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol (2010) 5.87
Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis (2010) 5.85
Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma. Gut (2003) 3.91
Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma. Clin Cancer Res (2012) 3.39
Targeted therapies for hepatocellular carcinoma. Gastroenterology (2011) 2.85
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo. J Hepatol (2009) 2.42
Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma. Hepatology (2012) 2.40
Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy. Annu Rev Med (2010) 1.86
Genetics of hepatobiliary carcinogenesis. Semin Liver Dis (2011) 1.79
Personalized medicine using DNA biomarkers: a review. Hum Genet (2012) 1.49
Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancers. Clin Cancer Res (2010) 1.48
The mTOR pathway is associated with the poor prognosis of human hepatocellular carcinoma. Med Oncol (2009) 1.46
PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways. Anticancer Res (2010) 1.43
Molecularly targeted therapy in hepatocellular carcinoma. Biochem Pharmacol (2010) 1.42
Epidermal growth factor receptor expression and gene copy number in conventional hepatocellular carcinoma. Am J Clin Pathol (2008) 1.41
Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma. Clin Cancer Res (2008) 1.40
Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma. J Cell Mol Med (2009) 1.30
Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells. J Hepatol (2012) 1.28
A melanoma molecular disease model. PLoS One (2011) 1.15
Molecularly targeted therapy for advanced hepatocellular carcinoma in 2012: current status and future perspectives. Semin Oncol (2012) 1.15
A novel classification of lung cancer into molecular subtypes. PLoS One (2012) 1.13
EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib. Int J Cancer (2012) 1.07
Leveling the playing field: bringing development of biomarkers and molecular diagnostics up to the standards for drug development. Clin Cancer Res (2012) 1.07
Second-line therapies in hepatocellular carcinoma: emergence of resistance to sorafenib. Clin Cancer Res (2012) 1.05
Overexpression of high-mobility group box 2 is associated with tumor aggressiveness and prognosis of hepatocellular carcinoma. Clin Cancer Res (2010) 1.04
Absence of epidermal growth factor receptor exon 18-21 mutation in hepatocellular carcinoma. Cancer Lett (2005) 1.00
Bridging the gap: moving predictive and prognostic assays from research to clinical use. Clin Cancer Res (2012) 0.99
Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma. J Hepatol (2012) 0.92
Coexpression of PDGFR-alpha, PDGFR-beta and VEGF as a prognostic factor in patients with hepatocellular carcinoma. Int J Biol Markers (2011) 0.91
Clinically relevant biomarkers to select patients for targeted inhibitor therapy after resection of hepatocellular carcinoma. Ann Surg Oncol (2011) 0.91
Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival. J Cancer Res Clin Oncol (2008) 0.90
Targeting vascular endothelial growth factor receptor-1 and -3 with cediranib (AZD2171): effects on migration and invasion of gastrointestinal cancer cell lines. Mol Cancer Ther (2009) 0.90
Lessons learned from 1,000 living donor liver transplantations in a single center: how to make living donations safe. Liver Transpl (2006) 2.58
Single-file diffusion of protein drugs through cylindrical nanochannels. ACS Nano (2010) 2.03
Biology of hepatocellular carcinoma. Ann Surg Oncol (2008) 1.78
Delayed hemorrhage after pancreaticoduodenectomy. J Am Coll Surg (2004) 1.59
Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol (2005) 1.57
Signal integration by Akt regulates CD8 T cell effector and memory differentiation. J Immunol (2012) 1.48
Efficacy of US-guided percutaneous cholecystocholangiography for the early exclusion and type determination of biliary atresia. Radiology (2011) 1.47
Rapid, large-scale generation of Ds transposant lines and analysis of the Ds insertion sites in rice. Plant J (2004) 1.31
Predicting survival after surgical resection for pancreatic ductal adenocarcinoma. Pancreas (2006) 1.25
Clinical outcomes of hepatic resection and radiofrequency ablation in patients with solitary colorectal liver metastasis. J Clin Gastroenterol (2008) 1.17
Solid pseudopapillary tumor of the pancreas: a multicenter study of 23 pediatric cases. J Pediatr Surg (2006) 1.16
Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice. J Clin Invest (2009) 1.15
Myogenic transcriptional activation of MyoD mediated by replication-independent histone deposition. Proc Natl Acad Sci U S A (2010) 1.14
SOX4 overexpression regulates the p53-mediated apoptosis in hepatocellular carcinoma: clinical implication and functional analysis in vitro. Carcinogenesis (2010) 1.13
The changes in coagulation profile and epidural catheter safety for living liver donors: a report on 6 years of our experience. Liver Transpl (2007) 1.10
Prognostic impact of microRNA-related gene polymorphisms on survival of patients with colorectal cancer. J Cancer Res Clin Oncol (2010) 1.09
Enhanced phytoremediation of volatile environmental pollutants with transgenic trees. Proc Natl Acad Sci U S A (2007) 1.07
Hepatocyte transplantation for glycogen storage disease type Ib. Cell Transplant (2007) 1.07
Long-term incidence, risk factors, and management of biliary complications after adult living donor liver transplantation. Liver Transpl (2006) 1.06
Association between daily environmental temperature and suicide mortality in Korea (2001-2005). Psychiatry Res (2010) 1.05
Overexpression of high-mobility group box 2 is associated with tumor aggressiveness and prognosis of hepatocellular carcinoma. Clin Cancer Res (2010) 1.04
Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma. Am J Surg (2006) 1.03
Classification of hybrid and altered Vibrio cholerae strains by CTX prophage and RS1 element structure. J Microbiol (2010) 1.03
Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis. J Exp Clin Cancer Res (2009) 1.02
Purine-based inhibitors of inositol-1,4,5-trisphosphate-3-kinase. Chembiochem (2002) 1.01
Attribution bias in ultra-high risk for psychosis and first-episode schizophrenia. Schizophr Res (2010) 0.99
Spheroid-based three-dimensional liver-on-a-chip to investigate hepatocyte-hepatic stellate cell interactions and flow effects. Lab Chip (2013) 0.99
A plasma-treated chalcogenide switch device for stackable scalable 3D nanoscale memory. Nat Commun (2013) 0.98
Neurologic complications in adult living donor liver transplant recipients. Clin Transplant (2007) 0.98
Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy. Cancer Chemother Pharmacol (2009) 0.98
TIS21 negatively regulates hepatocarcinogenesis by disruption of cyclin B1-Forkhead box M1 regulation loop. Hepatology (2008) 0.98
Adrenal ganglioneuroma with hepatic metastasis. J Korean Surg Soc (2011) 0.98
Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling. Ann Surg Oncol (2013) 0.98
Detection of human papillomavirus DNA by DNA chip in breast carcinomas of Korean women. Tumour Biol (2008) 0.97
Eotaxin and FGF enhance signaling through an extracellular signal-related kinase (ERK)-dependent pathway in the pathogenesis of Eosinophilic esophagitis. Allergy Asthma Clin Immunol (2010) 0.97
The expression of phospho-AKT1 and phospho-MTOR is associated with a favorable prognosis independent of PTEN expression in intrahepatic cholangiocarcinomas. Mod Pathol (2011) 0.97
Structural double-mutant cycle analysis of a hydrogen bond network in ketosteroid isomerase from Pseudomonas putida biotype B. Biochem J (2004) 0.95
Inactivation of glycogen synthase kinase-3β is required for osteoclast differentiation. J Biol Chem (2011) 0.94
Adiponectin receptor expression predicts favorable prognosis in cases of hepatocellular carcinoma. Pathol Oncol Res (2014) 0.94
Comparative interactomes of SIRT6 and SIRT7: Implication of functional links to aging. Proteomics (2014) 0.94
HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma. Ann Surg Oncol (2014) 0.94
Functional 3D human primary hepatocyte spheroids made by co-culturing hepatocytes from partial hepatectomy specimens and human adipose-derived stem cells. PLoS One (2012) 0.93
p53 alteration independently predicts poor outcomes in patients with endometrial cancer: a clinicopathologic study of 131 cases and literature review. Gynecol Oncol (2009) 0.93
The antimicrobial activity of compounds from the leaf and stem of Vitis amurensis against two oral pathogens. Bioorg Med Chem Lett (2009) 0.93
The effects of Internet addiction on the lifestyle and dietary behavior of Korean adolescents. Nutr Res Pract (2010) 0.92
Total scores of the CERAD neuropsychological assessment battery: validation for mild cognitive impairment and dementia patients with diverse etiologies. Am J Geriatr Psychiatry (2010) 0.92
Characterization of a novel Ser-cisSer-Lys catalytic triad in comparison with the classical Ser-His-Asp triad. J Biol Chem (2003) 0.91
Genetic polymorphism of interferon-gamma, interferon-gamma receptor, and interferon regulatory factor-1 genes in patients with hepatitis B virus infection. Biochem Genet (2006) 0.91
Risk factor stratification after simultaneous liver and colorectal resection for synchronous colorectal metastasis. Langenbecks Arch Surg (2007) 0.91
Hepatitis C virus NS5A protein increases hepatic lipid accumulation via induction of activation and expression of PPARgamma. FEBS Lett (2009) 0.91
HMGB2 stabilizes p53 by interfering with E6/E6AP-mediated p53 degradation in human papillomavirus-positive HeLa cells. Cancer Lett (2009) 0.90
Phase II study of docetaxel and capecitabine in patients with metastatic or recurrent gastric cancer. Oncology (2005) 0.90
Epithelial-mesenchymal transition gene signature to predict clinical outcome of hepatocellular carcinoma. Cancer Sci (2010) 0.89
Clinical usefulness of human cytomegalovirus antigenemia assay after kidney transplantation. Transplantation (2003) 0.89
Rapamycin inhibits both motility through down-regulation of p-STAT3 (S727) by disrupting the mTORC2 assembly and peritoneal dissemination in sarcomatoid cholangiocarcinoma. Clin Exp Metastasis (2012) 0.89
Ectopic pancreas bleeding in the jejunum revealed by capsule endoscopy. Clin Endosc (2012) 0.88
Microfluidic wet spinning of chitosan-alginate microfibers and encapsulation of HepG2 cells in fibers. Biomicrofluidics (2011) 0.88
High hilar dissection: new technique to reduce biliary complication in living donor liver transplantation. Liver Transpl (2004) 0.88
Origin of the different pH activity profile in two homologous ketosteroid isomerases. J Biol Chem (2003) 0.88
Surface modification for DNA and protein microarrays. OMICS (2006) 0.88
Outcome of donors with a remnant liver volume of less than 35% after right hepatectomy. Liver Transpl (2006) 0.87
Intrathecal morphine combined with intravenous patient-controlled analgesia is an effective and safe method for immediate postoperative pain control in live liver donors. Liver Transpl (2009) 0.87
Ischemic preconditioning and intermittent clamping confer protection against ischemic injury in the cirrhotic mouse liver. Liver Transpl (2008) 0.87
Metastatic hepatocellular carcinoma to the parotid gland: Case report and review of the literature. Int J Surg Case Rep (2012) 0.87
The effect of DNA mismatch repair (MMR) status on oxaliplatin-based first-line chemotherapy as in recurrent or metastatic colon cancer. Med Oncol (2009) 0.87
Reprogramming of the activity of the activator/dissociation transposon family during plant regeneration in rice. Mol Cells (2002) 0.86
Molecular cloning and characterization of a 2-deoxystreptamine biosynthetic gene cluster in gentamicin-producing Micromonospora echinospora ATCC15835. Mol Cells (2004) 0.86
Extracts of Magnoliae flos inhibit inducible nitric oxide synthase via ERK in human respiratory epithelial cells. Nitric Oxide (2008) 0.86
Does pretreatment HPV viral load correlate with prognosis in patients with early stage cervical carcinoma? J Gynecol Oncol (2008) 0.86
Intranasal immunization with influenza virus and Korean mistletoe lectin C (KML-C) induces heterosubtypic immunity in mice. Vaccine (2007) 0.86
Comparative proteomic analysis of mouse melanoma cell line B16, a metastatic descendant B16F10, and B16 overexpressing the metastasis-associated tyrosine phosphatase PRL-3. Oncol Res (2009) 0.86
Survival benefits of intra-arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis. Hepatol Res (2005) 0.86
Detection of an intermediate during the unfolding process of the dimeric ketosteroid isomerase. FEBS Lett (2006) 0.85
Recurrence of hepatocellular carcinoma after liver transplantation: patterns and prognostic factors based on clinical and radiologic features. AJR Am J Roentgenol (2007) 0.85
Clinical significance of genetic variations in the PI3K/PTEN/AKT/mTOR pathway in Korean patients with colorectal cancer. Oncology (2011) 0.85
Quantification of thalamocortical tracts in schizophrenia on probabilistic maps. Neuroreport (2008) 0.85
Biliary phytobezoar resulting in intestinal obstruction. World J Gastroenterol (2013) 0.85
PTEN regulation by the Akt/GSK-3β axis during RANKL signaling. Bone (2013) 0.85
Discordance between HbA1c and fasting plasma glucose criteria for diabetes screening is associated with obesity and old age in Korean individuals. Diabetes Res Clin Pract (2011) 0.85
Enhanced cardioprotective effects by coexpression of two isoforms of hepatocyte growth factor from naked plasmid DNA in a rat ischemic heart disease model. J Gene Med (2011) 0.85
The lipopolysaccharide-triggered mesangial transcriptome: Evaluating the role of interferon regulatory factor-1. Kidney Int (2005) 0.84
The relationship between psychosocial functioning and resilience and negative symptoms in individuals at ultra-high risk for psychosis. Aust N Z J Psychiatry (2013) 0.84
The conserved cis-Pro39 residue plays a crucial role in the proper positioning of the catalytic base Asp38 in ketosteroid isomerase from Comamonas testosteroni. Biochem J (2003) 0.84
Relationship between mortality and fine particles during Asian dust, smog-Asian dust, and smog days in Korea. Int J Environ Health Res (2012) 0.84
Natural form of noncytolytic flexible human Fc as a long-acting carrier of agonistic ligand, erythropoietin. PLoS One (2011) 0.84
Estimating the alcohol-breast cancer association: a comparison of diet diaries, FFQs and combined measurements. Eur J Epidemiol (2012) 0.84
Influence of preoperative transcatheter arterial chemoembolization on gene expression in the HIF-1α pathway in patients with hepatocellular carcinoma. J Cancer Res Clin Oncol (2014) 0.84